Merck KGaA's stock remains a 'hold' due to its high valuation, trading at an earnings multiple of around 20 and a 4.5% free ...

Merck KGaA sees forex-adjusted earnings growth of up to 8% this year Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...

E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board in a pivotal step in the company's ongoing growth strategy. Jean-Charles Wirth will ...

In a report released today, Matthew Weston from UBS maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of €190.00. See what stocks are receiving Strong Buy ...

Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production.

The board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on the 30th of April. This means the annual payment will be 1.6% of the current stock price ...

How Do Unusual Items Influence Profit? For anyone who wants to understand Merck KGaA's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Merck KGaA (0O14 – Research Report), with a price target of €185.00. See what stocks are receiving ...

Merck KGaA has made a series of acquisitions and divestitures in the past decade or so to position the group for solid long-term growth in three key segments: life sciences, electronics ...